EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieÄquivalenzstudieOpen Access · CC BY 4.0

Effect of a six-month vitamin D supplementation on depressive symptoms in patients with major depressive episode (DepFuD): a double-blinded randomised controlled trial

Tuomas Mikola, Soili M Lehto, Tommi Tolmunen, Kirsi Honkalampi, Minna Valkonen-Korhonen, Virpi Laukkanen, Maarit Pakarinen, Heli Koivumaa-Honkanen, Anu Ruusunen

Journal of Affective Disorders · 2026-08 · 406 · 121709

DOI: 10.1016/j.jad.2026.121709 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2026-08. Verfasst von Tuomas Mikola und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine, University of Eastern Finland, Kuopio Campus, Yliopistonranta 8, P.O. Box 1627, FI-70211, Kuopio, Finland. Electronic…. Hauptthemen laut MEDLINE: Dietary Supplements, Major Depressive Disorder, Vitamin D, Vitamins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Finnish Medical Foundation, University of Eastern Finland, Juho Vainio Fundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Initial studies suggest vitamin D (VD) supplementation may aid in treating major depressive disorder, but rigorous randomised controlled trials are needed. TRIAL DESIGN: DepFuD trial was a six-month, double-blinded, parallel-group, randomised controlled superiority design trial with a 1:1 allocation ratio. Outpatients with mild to severe depression episode, aged 18-65 years, were included. METHODS: The primary aim was to compare the effects of low-dose versus high-dose VD as adjunctive to participants' existing depression treatments, hypothesising that the high-dose group would show greater symptom reduction over six months. Participants were randomised to receive either 100 μg (4000 IU) or 10 μg (400 IU) of VD (cholecalciferol) daily for six months. The primary outcome was measured by between-group differential change over six months in the Montgomery-Åsberg Depression Rating Scale (MADRS) score (range: 0-60). Data was collected in Finland between November 2015 and December 2020. RESULTS: A total of 281 participants were randomised: 142 in the low-dose and 139 in the high-dose group. At baseline, 46% of the participants in low-dose and 42% in high-dose group had VD deficiency (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsMajor Depressive DisorderVitamin DVitaminsAdolescentAdultFemaleHumansMaleMiddle AgedYoung AdultDouble-Blind MethodFinlandPsychiatric Status Rating ScalesTreatment OutcomeAged

Stichwörter der Autor:innen

DepressionDepressive symptomsInterventionMental healthVitamin D

Substanzen

Vitamin DVitamins

Autor:innen und Institutionen

  • Institute of Clinical Medicine, University of Eastern Finland, Kuopio Campus, Yliopistonranta 8, P.O. Box 1627, FI-70211, Kuopio, Finland. Electronic address: t.h.mikola@gmail.com.
  • Institute of Clinical Medicine, University of Oslo, P.O. Box 1171 Blindern, 0318, Oslo, Norway; R&D Department, Division of Mental Health Services, Akershus University Hospital, P.O. Box 1000, 1478, Lørenskog, Norway; D…
  • Institute of Clinical Medicine, University of Eastern Finland, Kuopio Campus, Yliopistonranta 8, P.O. Box 1627, FI-70211, Kuopio, Finland; Department of Mental Health and Wellbeing, Kuopio University Hospital, Wellbeing…
  • Department of Education and Psychology, University of Eastern Finland, Joensuu Campus, Yliopistokatu 2, P.O. Box 111, FI-80101, Joensuu, Finland.
  • Institute of Clinical Medicine, University of Eastern Finland, Kuopio Campus, Yliopistonranta 8, P.O. Box 1627, FI-70211, Kuopio, Finland.
  • Department of Mental Health and Wellbeing, Kuopio University Hospital, Wellbeing Services County of North Savo, Puijonlaaksontie 2, 70210, Kuopio, Finland; IMPACT - The Institute for Mental and Physical Health and Clini…

Förderung

  • Finnish Medical Foundation
  • University of Eastern Finland
  • Juho Vainio Fundation

Zitieren

APA

Mikola, T., Lehto, S. M., Tolmunen, T., Honkalampi, K., Valkonen-Korhonen, M., Laukkanen, V., Pakarinen, M., Koivumaa-Honkanen, H., & Ruusunen, A. (2026). Effect of a six-month vitamin D supplementation on depressive symptoms in patients with major depressive episode (DepFuD): a double-blinded randomised controlled trial. Journal of Affective Disorders, 406, 121709. https://doi.org/10.1016/j.jad.2026.121709

Vancouver

Mikola T, Lehto SM, Tolmunen T, Honkalampi K, Valkonen-Korhonen M, Laukkanen V, et al. Effect of a six-month vitamin D supplementation on depressive symptoms in patients with major depressive episode (DepFuD): a double-blinded randomised controlled trial. Journal of Affective Disorders. 2026;406:121709. doi:10.1016/j.jad.2026.121709

BibTeX
@article{Mikola2026,
  author = {Mikola, Tuomas and Lehto, Soili M and Tolmunen, Tommi and Honkalampi, Kirsi and Valkonen-Korhonen, Minna and Laukkanen, Virpi and Pakarinen, Maarit and Koivumaa-Honkanen, Heli and Ruusunen, Anu},
  title = {Effect of a six-month vitamin D supplementation on depressive symptoms in patients with major depressive episode (DepFuD): a double-blinded randomised controlled trial},
  journal = {Journal of Affective Disorders},
  year = {2026},
  volume = {406},
  pages = {121709},
  doi = {10.1016/j.jad.2026.121709}
}
Kostenlos starten →